Skip to Content

TE VA 7629 (Imatinib Mesylate 100 mg)

Pill with imprint TE VA 7629 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TE VA 7629

Imatinib Mesylate

Imprint:
TE VA 7629
Strength:
100 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):
00093-7629

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide